Biotech Investors & VC Firms in North America
1593 firms in this list, with a median first check of $500K. 347 of them lead rounds. Generated from verified public data and updated continuously.
Yu Galaxy
Silicon ValleyPre-Seed–Seed
2 people
Global Health Investment Fund
New York
1 person
adMare BioInnovations
VancouverSeed
ROC Venture Group
NaplesSeed–Series A
venture / science
San Francisco Bay AreaSeed–Late Stage
2 people
Curative Ventures
Dallas
1 person
Paragon Biosciences LLC
ChicagoSeed–Series A
1 person
View Ventures
DallasSeed–Series A
1 person
De Novo Ventures
Boston
6 people
Curious Office Partners
BoiseSeed
1 person
Threshold Impact
KelownaSeed
1 person
Trans-it Capital
Palo AltoSeed
1 person
Hub Angels
BostonSeed–Series A
Pura Vida Investments
New YorkLate Stage
BDC Life Sciences Venture Fund
MontrealSeed–Series A
2 people
EQx Fund
BostonPre-Seed–Series A
1 person
HaloHealth
TorontoPre-Seed–Seed
1 person
Venbridge
TorontoSeed–Late Stage
1 person
The Kraft Group
FoxboroughSeries A
Ambix Venture Management, Llc
Mountain ViewPre-Seed–Late Stage
2 people
Dalena Capital
Palo AltoSeed
2 people
Isenberg Ventures
MontrealSeed–Series A
2 people
PFM Health Sciences
San FranciscoPre-Seed–Series A
2 people
Riverine Ventures
Sausalito
2 people
Related lists
Investors & VC Firms in North America (13518)Investors & VC Firms in United States (12555)Investors & VC Firms in Europe (5846)Investors & VC Firms in Global (4720)AI & Machine Learning Investors & VC Firms (4549)Fintech Investors & VC Firms (4537)SaaS Investors & VC Firms (4215)Healthtech Investors & VC Firms (4185)Enterprise Software Investors & VC Firms (4097)Crypto & Web3 Investors & VC Firms (3965)
Data sourced from public filings and firms' own websites — see our methodology.
























